![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | RGD:1353989 | 6480464 | Demecolcine results in increased expression of RAB11FIP3 mRNA | CTD | PMID:23649840 | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1551905 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:36331819 | 1,1,1-trichloroethane | increases expression | ISO | RGD:1551905 | 6480464 | 1 more ... | CTD | PMID:25270620 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551905 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB11FIP3 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:33387578 | 2-methylcholine | affects expression | ISO | RGD:1353989 | 6480464 | beta-methylcholine affects the expression of RAB11FIP3 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RAB11FIP3 mRNA | CTD | PMID:30071829 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:1551905 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of RAB11FIP3 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1551905 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of RAB11FIP3 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB11FIP3 mRNA | CTD | PMID:36041667 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1551905 | 6480464 | Fenretinide results in increased expression of RAB11FIP3 mRNA | CTD | PMID:28973697 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RAB11FIP3 mRNA | CTD | PMID:16483693 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | RGD:1353989 | 6480464 | Antirheumatic Agents results in increased expression of RAB11FIP3 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | RGD:1353989 | 6480464 | aristolochic acid I results in increased expression of RAB11FIP3 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | RGD:1353989 | 6480464 | Arsenic affects the methylation of RAB11FIP3 gene | CTD | PMID:25304211 | arsane | multiple interactions | ISO | RGD:1353989 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAB11FIP3 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | RGD:1353989 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAB11FIP3 mRNA | CTD | PMID:32525701 | arsenic atom | affects methylation | ISO | RGD:1353989 | 6480464 | Arsenic affects the methylation of RAB11FIP3 gene | CTD | PMID:25304211 | atrazine | decreases expression | ISO | RGD:1353989 | 6480464 | Atrazine results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | RGD:1551905 | 6480464 | Benzo(a)pyrene results in increased expression of RAB11FIP3 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | RGD:1353989 | 6480464 | Benzo(a)pyrene affects the methylation of RAB11FIP3 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RAB11FIP3 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB11FIP3 mRNA | CTD | PMID:36041667 | bisphenol A | multiple interactions | ISO | RGD:1353989 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RAB11FIP3 gene | CTD | PMID:31601247 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RAB11FIP3 mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB11FIP3 mRNA | CTD | PMID:36041667 | caffeine | increases phosphorylation | ISO | RGD:1353989 | 6480464 | Caffeine results in increased phosphorylation of RAB11FIP3 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | RGD:1551905 | 6480464 | Nanotubes, Carbon analog results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:25554681 | cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:18500788 | CGP 52608 | multiple interactions | ISO | RGD:1353989 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RAB11FIP3 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | RGD:1551905 | 6480464 | Chlorpyrifos results in increased expression of RAB11FIP3 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | RGD:1551905 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | RGD:1353989 | 6480464 | Cisplatin results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | RGD:1353989 | 6480464 | Copper Sulfate results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases methylation | ISO | RGD:1353989 | 6480464 | Cyclosporine results in decreased methylation of RAB11FIP3 promoter | CTD | PMID:27989131 | diclofenac | increases expression | ISO | RGD:1551905 | 6480464 | Diclofenac results in increased expression of RAB11FIP3 mRNA | CTD | PMID:26934552 | dorsomorphin | multiple interactions | ISO | RGD:1353989 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:27188386 | ethanol | multiple interactions | ISO | RGD:1551905 | 6480464 | Ethanol affects the expression of and affects the splicing of RAB11FIP3 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | RGD:1551905 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RGD:1353989 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RAB11FIP3 gene | CTD | PMID:31601247 | L-methionine | multiple interactions | ISO | RGD:1551905 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:20938992 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of RAB11FIP3 mRNA | CTD | PMID:24136188 | levonorgestrel | multiple interactions | ISO | RGD:1353989 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:19074003 | malathion | increases expression | ISO | RGD:1353989 | 6480464 | Malathion results in increased expression of RAB11FIP3 mRNA | CTD | PMID:32069766 | mercury dichloride | decreases expression | EXP | | 6480464 | Mercuric Chloride results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:16507785 | methyl methanesulfonate | increases expression | ISO | RGD:1353989 | 6480464 | Methyl Methanesulfonate results in increased expression of RAB11FIP3 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | RGD:1353989 | 6480464 | methylmercuric chloride results in increased expression of RAB11FIP3 mRNA | CTD | PMID:23179753 | paracetamol | decreases expression | ISO | RGD:1353989 | 6480464 | Acetaminophen results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:21420995 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RAB11FIP3 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | RGD:1551905 | 6480464 | Acetaminophen affects the expression of RAB11FIP3 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1551905 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:36331819 | SB 431542 | multiple interactions | ISO | RGD:1353989 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:27188386 | sodium arsenate | multiple interactions | ISO | RGD:1353989 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAB11FIP3 mRNA | CTD | PMID:32525701 | temozolomide | increases expression | ISO | RGD:1353989 | 6480464 | Temozolomide results in increased expression of RAB11FIP3 mRNA | CTD | PMID:31758290 | testosterone undecanoate | multiple interactions | ISO | RGD:1353989 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:19074003 | valproic acid | affects expression | ISO | RGD:1353989 | 6480464 | Valproic Acid affects the expression of RAB11FIP3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1353989 | 6480464 | Valproic Acid results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1353989 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:27188386 | vincristine | increases expression | ISO | RGD:1353989 | 6480464 | Vincristine results in increased expression of RAB11FIP3 mRNA | CTD | PMID:23649840 | vorinostat | decreases expression | ISO | RGD:1353989 | 6480464 | vorinostat results in decreased expression of RAB11FIP3 mRNA | CTD | PMID:27188386 | |